Delivery Order SPE2DB22D2214-SPE2DB25FS6NN
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $36,330.77 to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewable units of use on August 7, 2025, with completion targeted for August 8, 2025. This firm fixed-price contract represents a non-competitive delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026....
- The Defense Logistics Agency awarded a delivery order valued at $11,190.41 to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewable units on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed price, competitively awarded delivery order represents a single-item pharmaceutical procurement with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,232.22 to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewable units of supply on August 19, 2025. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of August 20, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $19,065.20 to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewable units. This non-competitive, firm fixed-price delivery order was issued on July 21, 2025, with an ultimate completion date of July 22, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $8,427.06 to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewable units under a firm fixed price contract type. This non-set-aside award was issued on August 8, 2025, with an ultimate completion date of August 11, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a prime contractor for the DLA and is a major pharmaceutical distributor specializing in medical supply chain support for federal...
- The Defense Logistics Agency awarded a $21,691.13 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewables under unit dose strip packaging. This competitively awarded contract, with no set-aside designation, was executed on September 2, 2025, with an ultimate completion date of September 3, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance. This delivery order is issued against...
- The Defense Logistics Agency awarded a delivery order valued at $6,317.21 to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewable units under delivery order contract 4569293882. The award, issued on September 2, 2025, with an ultimate completion date of September 3, 2025, represents a firm fixed price, competitively awarded contract with no set-aside designation. Performance will be conducted at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 5, 2025, for the supply of Emverm 100 mg tablet chewables, with a ceiling value of $32,123.06. The contract is structured as a firm fixed price delivery order with an ultimate completion date of August 6, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This award utilized no set-aside designation and was competitively awarded to the...
- The Defense Logistics Agency awarded a delivery order valued at $125,392.88 to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewable units of issue on September 3, 2025, with an ultimate completion date of September 4, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp Corporate Office Division, a major pharmaceutical distributor, for the supply of EMVERM 100 MG TABLET CHEW UDS. The order, valued at $33,296.99, is a firm fixed-price contract with an ultimate completion date of August 19, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, to provide a...
- SPE2DB22D2214Indefinite Delivery Contract
- SPE2DB22D2214-SPE2DB25FS6NNDelivery Order
The Defense Logistics Agency awarded a $39,912.75 firm fixed price delivery order to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewable units on September 12, 2025, with completion targeted for September 15, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain. AmerisourceBergen's award portfolio with the Defense Logistics Agency demonstrates the company's established capability to fulfill diverse federal pharmaceutical requirements on a competitive basis. The parent IDC vehicle enables the contractor to supply a comprehensive range of pharmaceutical products and medical supplies globally, supporting military healthcare programs and other government healthcare systems including the Defense Health Agency and U.S. Coast Guard. This delivery order for Emverm tablets exemplifies the routine pharmaceutical supply fulfillment conducted under the broader prime vendor agreement, which is part of DLA's strategic approach to pharmaceutical distribution involving multiple regional contractors.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $39.9k | 9/12/25 |